Jim O’shea
Non-executive director
BTG plc
Australia
Biography
Jim O’Shea was appointed to the Board in April 2009. He is a member of the Nomination Committee. Other directorships: Jim serves as Chairman of Cardiome Pharma, is a director of Trevi Therapeutics, Inc., and Ocular Therapeutix™. Expertise and experience: Jim provides the Board with significant US Industry experience. He is a former Chairman of the US National Pharmaceuticals Council. From 2007 to 2008, he was Vice Chairman of Sepracor, Inc., where he was also President and Chief Operating Officer from 1999 to 2007. Previously Jim was Senior Vice President of Sales & Marketing and Medical Affairs for Zeneca Pharmaceuticals (US), a business unit of Zeneca Inc. While at Zeneca, he held several management positions of increasing responsibility in international sales and marketing in the US and the UK.
Research Interest
Research interest on sales Marketing
